My assessment of the report is excellent. Everything is consistent with past information and expectations built on those reports.
All physical attributes and ease of use is confirmed. Signal quality is said to be high. The main outstanding piece is the algorithm. EMV reports advances with AI the algorithm. The results of imaging 120 patients have lead to confirmation that the global launch will go ahead at the end of November. In my book that is an indicator of a high level of confidence on the imaging capability of the algorithm.
Why is the market reluctant? What have I missed?
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.74 |
Change
0.000(0.00%) |
Mkt cap ! $148.3M | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.75 | $1.72 | $33.12K | 19.11K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17908 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 21294 | 2 |
View Market Depth
| Last trade - 15.58pm 23/07/2025 (20 minute delay) ? |
| EMV (ASX) Chart |